MP to Strengthen Drug Control System: State Minister Patel

Bhopal, Madhya Pradesh– State Minister Shri Patel announced plans to fortify the drug control mechanism across Madhya Pradesh, emphasizing stricter enforcement and better monitoring to curb violations in pharmaceutical distribution and sales.

The initiative, revealed during a review meeting, targets improvements in inspection protocols and licensing to ensure compliance with national standards. Officials highlighted the need for more rigorous audits amid rising concerns over counterfeit drugs.
Key measures include enhanced training for inspectors and integration of digital tracking tools. The minister stressed that these steps will safeguard public health and support legitimate businesses. Implementation is set to begin next month.

Related Posts

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

New Delhi: Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Levothyroxine Sodium Tablets USP in…

STF busts fake meds racket spread across 6 states

Dehradun: Uttarakhand special task force (STF) on Friday busted an online fake medicine racket operating through a Facebook page that allegedly sold counterfeit drugs, including cancer medicines, at discounts of…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

Alembic Pharma Secures USFDA Approval for Generic Synthroid Tablets

STF busts fake meds racket spread across 6 states

STF busts fake meds racket spread across 6 states

All the Way from Teeth to Tee: Hole in One

All the Way from Teeth to Tee: Hole in One

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug